Monday, January 28, 2019
Researchers investigate coated Prussian blue nanoparticles for cancer immunotherapies
The researchers will work with Prussian blue nanoparticles (PBNPs) coated with immunological signals, used in combination with checkpoint inhibitors.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment